A

Alkem Laboratories Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 19 analysts offering recommendations for Alkem Laboratories Ltd

47%

Buy

32%

Hold

21%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio37.1750.26
PB Ratio6.236.38
Dividend Yield0.72%0.53%

Understand what these metrics mean. 

About the company

A

Alkem Laboratories Ltd

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions